CS logo
small CS logo
NYU Langone Medical Center - NYU Medical Oncology Associates

New York, New York, United States

About NYU Langone Medical Center - NYU Medical Oncology Associates


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at NYU Langone Medical Center - NYU Medical Oncology Associates


During the past decade, NYU Langone Medical Center - NYU Medical Oncology Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000022110000000000Started TrialsCompleted Trails201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
2017-03-05
2020-07-27
Terminated
43
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
2020-12-16
2025-06-01
Active, not recruiting
300
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
2020-01-23
2022-08-01
Active, not recruiting
54
An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.
2021-05-10
2023-12-18
Active, not recruiting
227

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Medical Center - NYU Medical Oncology Associates" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at NYU Langone Medical Center - NYU Medical Oncology Associates


According to Clinical.Site data, the most researched conditions in "NYU Langone Medical Center - NYU Medical Oncology Associates" are "Colorectal Cancer" (1 trials), "Gastric Cancer" (1 trials), "Gastroesophageal Junction Adenocarcinoma" (1 trials), "Glioblastoma" (1 trials) and "Lymphoma, Non-Hodgkin" (1 trials). Many other conditions were trialed in "NYU Langone Medical Center - NYU Medical Oncology Associates" in a lesser frequency.

Clinical Trials Intervention Types at NYU Langone Medical Center - NYU Medical Oncology Associates


Most popular intervention types in "NYU Langone Medical Center - NYU Medical Oncology Associates" are "Drug" (4 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "AB680" (1 trials), "Bendamustine" (1 trials), "Enzastaurin Hydrochloride" (1 trials), "Gemcitabine" (1 trials) and "Ibrutinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at NYU Langone Medical Center - NYU Medical Oncology Associates


The vast majority of trials in "NYU Langone Medical Center - NYU Medical Oncology Associates" are 4 trials for "All" genders.

Clinical Trials Status at NYU Langone Medical Center - NYU Medical Oncology Associates


Currently, there are NaN active trials in "NYU Langone Medical Center - NYU Medical Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in NYU Langone Medical Center - NYU Medical Oncology Associates, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in NYU Langone Medical Center - NYU Medical Oncology Associates, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status